Luca Quattrini

423 total citations
20 papers, 351 citations indexed

About

Luca Quattrini is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Luca Quattrini has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Organic Chemistry. Recurrent topics in Luca Quattrini's work include Aldose Reductase and Taurine (7 papers), Cannabis and Cannabinoid Research (3 papers) and Prenatal Substance Exposure Effects (3 papers). Luca Quattrini is often cited by papers focused on Aldose Reductase and Taurine (7 papers), Cannabis and Cannabinoid Research (3 papers) and Prenatal Substance Exposure Effects (3 papers). Luca Quattrini collaborates with scholars based in Italy, Egypt and Taiwan. Luca Quattrini's co-authors include Concettina La Motta, Vito Coviello, Stefania Sartini, Silvia Garavaglia, Davide M. Ferraris, Mattia Mori, Ichiro Nakano, Ahmed A. El‐Rashedy, Kamel Metwally and Mahmoud E. S. Soliman and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Luca Quattrini

19 papers receiving 348 citations

Peers

Countries citing papers authored by Luca Quattrini

Since Specialization

Citations

This map shows the geographic impact of Luca Quattrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Quattrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Quattrini more than expected).

Fields of papers citing papers by Luca Quattrini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Quattrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Quattrini. The network helps show where Luca Quattrini may publish in the future.

Co-authorship network of co-authors of Luca Quattrini

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Quattrini. A scholar is included among the top collaborators of Luca Quattrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Quattrini. Luca Quattrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study 2025 ·European Journal of Pharmaceutics and Biopharmaceutics ·Ilaria Piano, Beatrice Polini, (unknown), Sara Carpi, (unknown), Luca Quattrini, Ilaria D’Agostino, Maria Cristina Gamberini, Cecilia Baraldi, Grazia Chiellini, Paola Nieri, Concettina La Motta, Claudia Gargini	0
2	Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation 2022 ·Marine Drugs ·Alessandra Bertoli, (unknown), Luca Quattrini, Stefania Sartini, Beatrice Polini, Sara Carpi, (unknown), Graziano Di Giuseppe, Graziano Guella, Paola Nieri, Concettina La Motta	3
3	Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Felicia D’Andrea, Stefania Sartini, Ilaria Piano, (unknown), Luca Quattrini, Lorenzo Guazzelli, Lidia Ciccone, Elisabetta Orlandini, Claudia Gargini, Concettina La Motta, Susanna Nencetti	7
4	Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target 2020 ·Biomedicines ·Luca Quattrini, (unknown), (unknown), Norman J. Maitland, Fiona M. Frame, Klaus Pors, Concettina La Motta	10
5	Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells 2020 ·Journal of Medicinal Chemistry ·Luca Quattrini, (unknown), Vito Coviello, Stefania Sartini, Davide M. Ferraris, Mattia Mori, Ichiro Nakano, Silvia Garavaglia, Concettina La Motta	53
6	Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family 2020 ·ACS Medicinal Chemistry Letters ·Luca Quattrini, (unknown), (unknown), Giorgia Colombo, Davide M. Ferraris, (unknown), Menico Rizzi, Silvia Garavaglia, Concettina La Motta	21
7	A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-α 2019 ·Saudi Pharmaceutical Journal ·Serena Del Turco, Luca Quattrini, Rocchina Colucci, Melania Gaggini, Concettina La Motta, Giuseppina Basta	2
8	Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 2019 ·Bioorganic Chemistry ·Lorenzo Guazzelli, Felicia D’Andrea, Stefania Sartini, (unknown), (unknown), Luca Quattrini, Ilaria Piano, Susanna Nencetti, Elisabetta Orlandini, Claudia Gargini, Concettina La Motta	19
9	Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation 2019 ·Scientific Reports ·Luca Quattrini, Vito Coviello, Stefania Sartini, Teresa Di Desidero, Paola Orlandi, Yi-Yu Ke, (unknown), Hsing‐Pang Hsieh, Guido Bocci, Concettina La Motta	4
10	Aldose reductase inhibitors: 2013-present 2019 ·Expert Opinion on Therapeutic Patents ·Luca Quattrini, Concettina La Motta	77
11	Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 2018 ·Cell chemical biology ·Francesco Balestri, Luca Quattrini, Vito Coviello, Stefania Sartini, Federico Da Settimo, Mario Cappiello, Roberta Moschini, Antonella Del Corso, Umberto Mura, Concettina La Motta	18
12	Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 2018 ·Frontiers in Endocrinology ·Silvia Martina Ferrari, Concettina La Motta, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Luca Quattrini, Sabrina Rosaria Paparo, Simona Piaggi, Armando Patrizio, Salvatore Ulisse, Enke Baldini, Gabriele Materazzi, Poupak Fallahi, Alessandro Antonelli	20
13	Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 2018 ·European Journal of Medicinal Chemistry ·Valeria La Pietra, Stefania Sartini, Lorenzo Botta, Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, Alessio Moriconi, Vito Coviello, Luca Quattrini, Yi-Yu Ke, Hsing‐Pang Hsieh, Federico Da Settimo, Ettore Novellino, Concettina La Motta, Luciana Marinelli	15
14	Soyasaponins from Zolfino bean as aldose reductase differential inhibitors 2018 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Francesco Balestri, Marinella De Leo, Carlo Sorce, Mario Cappiello, Luca Quattrini, Roberta Moschini, (unknown), Alessandra Braca, Concettina La Motta, Federico Da Settimo, Antonella Del Corso, Umberto Mura	13
15	Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Kamel Metwally, (unknown), Lobna M. Abdel‐Aziz, Ahmed A. El‐Rashedy, Mahmoud E. S. Soliman, Luca Quattrini, Vito Coviello, Concettina La Motta	23
16	Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Vito Coviello, Stefania Sartini, Luca Quattrini, Cecilia Baraldi, Maria Cristina Gamberini, Concettina La Motta	24
17	Novel Quinazolinone-Based 2,4-Thiazolidinedione-3-Acetic Acid Derivatives as Potent Aldose Reductase Inhibitors 2017 ·Future Medicinal Chemistry ·Kamel Metwally, Harris Pratsinis, Dimitris Kletsas, Luca Quattrini, Vito Coviello, Concettina La Motta, Ahmed A. El‐Rashedy, Mahmoud E. S. Soliman	18
18	1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 2016 ·Journal of Medicinal Chemistry ·Vito Coviello, (unknown), Stefania Sartini, Luca Quattrini, Anna María Marini, Francesca Simorini, Sabrina Taliani, Silvia Salerno, Paola Orlandi, Anna Fioravanti, Teresa Di Desidero, Daniela Vullo, Federico Da Settimo, Claudiu T. Supuran, Guido Bocci, Concettina La Motta	21
19	Long-term therapy of patients with heart failure. Drug therapy: from trial results to clinical practice 1995 ·Archives of Gerontology and Geriatrics ·Luca Quattrini, (unknown), E Paciaroni	2
20	[The use of transvenous endocardiac electrostimulation in clinical practice]. 1967 ·PubMed ·(unknown), (unknown), (unknown), Luca Quattrini, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact